Market Closed - Australian S.E. 11:32:57 2023-02-27 pm EST 5-day change 1st Jan Change
0.001 AUD -.--% Intraday chart for ANALYTICA -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Analytica Appoints Voluntary Administrators MT
Analytica CEO Resigns MT
Dr Michael Monsour Will Take on the Role of Executive Chairman of Analytica Limited CI
Analytica Limited Announces Resignation of Geoff Daly as CEO CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Analytica Limited Auditor Raises 'Going Concern' Doubt CI
Analytica Secures Canadian Patent for Pelvic Floor Exercise System MT
Analytica Secures European, Indian Patent for Training Device MT
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Analytica Secures US Patent for PeriCoach Device MT
Analytica Limited Auditor Raises 'Going Concern' Doubt CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Analytica : Secures US Patent for Pelvic Floor Exercise System MT
Analytica Announces Expansion of Enhanced Infusion System into Middle East CI
Analytica : Plans Up to $3 Million Share Placement MT
Analytica : Enters Deal to Distribute Intravenous Flow Monitoring Device in Middle East MT
Analytica Limited Enters into Joint Venture Agreement to Manufacture, Distribute and Market the System in China, Macau, Hong Kong and Taiwan CI
Analytica Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020 CI
Analytica Ltd Announces Publication of an Independent Clinical Trial from the University of New Mexico in the Journal of Female Pelvic Medicine & Reconstructive Surgery, the Official Journal of the American Urogynecologic Society, Demonstrating PeriCoach Non-Inferiority to In- Clinic Pelvic Floor Physical Therapy CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2020 CI
Analytica Ltd Announces Resignation of Thomas Lönngren, Non-Executive Director CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2019 CI
Analytica Ltd Announces Middle East Distribution Agreement Supplementary Disclosure CI
Analytica Ltd. Reports Earnings Results for the Full Year Ended June 30, 2019 CI
Chart ANALYTICA
More charts
Analytica Limited is an Australia-based product development and commercialization company that is focused on Class I and II medical device products. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The Company is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. It is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.
More about the company
  1. Stock Market
  2. Equities
  3. ALT Stock
  4. News ANALYTICA
  5. Analytica Secures US Patent for PeriCoach Device